{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:44:37Z","timestamp":1774341877777,"version":"3.50.1"},"reference-count":36,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T00:00:00Z","timestamp":1138060800000},"content-version":"vor","delay-in-days":1425,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2002,3]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> The endometrial lining of the human uterus is a highly specialized, steroid\u2010sensitive tissue. Throughout the reproductive years, the endometrium undergoes dramatic cycles of growth, differentiation, and breakdown under the influence of ovarian steroids. In response to changes in steroid exposure throughout the menstrual cycle, the endometrium produces an array of bioactive growth factors and other cytokines that are critical components of paracrine communication. For example, cell\u2010cell communication via paracrine factors directs the expression of matrix metalloproteinases (MMPs), enzymes that mediate tissue remodeling during the menstrual cycle. The disease endometriosis is thought to occur as a consequence of retrograde menstruation, and MMPs appear to contribute to the establishment and progression of ectopic endometrial growth in the peritoneal cavity. Although the risk for developing endometriosis is linked to a woman's steroid exposure, locally produced paracrine factors can modify steroid action on multiple gene targets, including the MMPs. Estrogen\u2010associated growth factors as well as inflammatory cytokines are potent stimulators of MMP expression and may contribute to the ability of endometrial fragments to invade the peritoneal surface and establish ectopic sites of growth. In contrast, paracrine factors associated with progesterone action during early pregnancy inhibit MMP expression and prevent ectopic endometrial growth in an experimental model. For example, locally produced retinoic acid and transforming growth factor\u2010\u03b2 (TGF\u2010\u03b2) act in concert with progesterone to suppress MMPs, while enhancing expression of MMP inhibitors (TIMPs) during endometrial differentiation. Targeting pregnancy\u2010associated factors that inhibit endometrial\u2010specific MMP expression and action may enhance the effectiveness of progestin\u2010related treatments for endometriosis.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2002.tb02774.x","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T17:57:33Z","timestamp":1247162253000},"page":"139-146","source":"Crossref","is-referenced-by-count":44,"title":["Paracrine Mediators of Endometrial Matrix Metalloproteinase Expression"],"prefix":"10.1111","volume":"955","author":[{"given":"KEVIN G.","family":"OSTEEN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAYLON L.","family":"BRUNER\u2010TRAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAVID","family":"ONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ESTHER","family":"EISENBERG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,7,7]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(15)30003-X"},{"key":"e_1_2_7_3_2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0002-9378(58)90011-5","article-title":"Experimental endometriosis in the human","volume":"76","author":"Ridley J.H.","year":"1958","journal-title":"Am. J. Obstet. Gynecol."},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/jama.1986.03370140102032","article-title":"The relation of endometriosis to menstrual characteristics, smoking, and exercise","volume":"255","author":"Cramer D.W.","year":"1986","journal-title":"J. Am. Med. Assoc."},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1986.tb07995.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/oxfordjournals.epirev.a036270","article-title":"Evidence for the risk of pelvic endometriosis by age, race, and socioeconomic status","volume":"6","author":"Houston D.E.","year":"1984","journal-title":"Epidemiol."},{"key":"e_1_2_7_7_2","unstructured":"Halme J. & D. Stovall. 1995. Endometriosis and its medical management.InReproductive Medicine and Surgery pp. 695\u2010710. Mosby. St. Louis."},{"key":"e_1_2_7_8_2","unstructured":"Speroff L. R.H. Glass & N.G. Kase. 1998. Clinical Gynecologic Endocrinology and Infertility. Fifth edition pp. 1063\u20101067. Williams & Wilkins. Baltimore."},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(80)90069-6"},{"key":"e_1_2_7_10_2","unstructured":"Olive D.L. 1989. Medical treatment: alternatives to danazol.InEndometriosis: Contemporary Concepts and Clinical Management p. 60. Lippincott. Philadelphia."},{"key":"e_1_2_7_11_2","first-page":"73","article-title":"Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians","volume":"43","author":"Kaunitz A.M.","year":"1998","journal-title":"Int. J. Fertil. Women's Med."},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod64.5.1285"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117461"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(12)90922-9"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000052863"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119478"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.3.1118"},{"key":"e_1_2_7_18_2","doi-asserted-by":"crossref","unstructured":"Bruner\u2010Tran K.L. E. Eisenberg & K.G. Osteen. 2000 (October). Establishment of experimental endometriosis by eutopic or ectopic endometrial tissue acquired from women with endometriosis cannot be prevented by progesterone treatments [abstract]. Presented at the Fifty\u2010sixth Annual Meeting of the American Society for Reproductive Medicine San Diego.","DOI":"10.1016\/S0015-0282(00)00779-2"},{"key":"e_1_2_7_19_2","unstructured":"Segars J.H. 1997. Endometriosis and nuclear hormone receptors.InEndometrium and Endometriosis pp. 321\u2010332. Blackwell Science. Malden MA."},{"key":"e_1_2_7_20_2","unstructured":"Bruner K.L. N.R. Keller & K.G. Osteen. 1999. Interleukin\u20101\u03b1 opposes suppression of human endometrial matrix metalloproteinases by progesterone in a model of experimental endometriosis.InUnderstanding and Managing Endometriosis: Advances in Research and Practice pp. 123\u2010130. Parthenon. Pearl River NY."},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.4.1611"},{"issue":"1","key":"e_1_2_7_22_2","first-page":"230","article-title":"Progesterone or retinoic acid treatment of human endometrial tissue reduces basal and cytokine\u2010stimulated MMP expression and increases TIMP\u20101 secretion","volume":"62","author":"Osteen K.G.","year":"2000","journal-title":"Biol. Reprod."},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.141.2.7323"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.42.6.753"},{"key":"e_1_2_7_25_2","first-page":"61","article-title":"Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling","volume":"15","author":"Giguere V.","year":"1994","journal-title":"Endocr. Rev."},{"key":"e_1_2_7_26_2","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/oxfordjournals.humrep.a138720","article-title":"Cellular retinoid binding proteins and nuclear retinoic acid receptors in endometrial epithelial cells","volume":"9","author":"Siddiqui N.A.","year":"1994","journal-title":"Hum. Reprod."},{"key":"e_1_2_7_27_2","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/oxfordjournals.humrep.a136137","article-title":"Variation in the expression of cellular retinoid binding proteins in human endometrium throughout the menstrual cycle","volume":"10","author":"Loughney A.D.","year":"1995","journal-title":"Hum. Reprod."},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0945-053X(97)90026-3"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)55437-5"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1016334"},{"key":"e_1_2_7_31_2","unstructured":"Osteen K.G. K.L. Bruner E. Sierra\u2010Rivera & L.I. Gold. 1997. Progesterone and transforming growth factor\u2010\u03b2 co\u2010mediate matrix metalloproteinase expression in a model of endometriosis.InInternational Congress Symposium and Seminar Series Vol. 13 Endometriosis Today pp. 200\u2010209. Parthenon. Lancaster."},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.16.7362"},{"key":"e_1_2_7_33_2","first-page":"303","article-title":"The role for transforming growth factor\u2010\u03b2 (TGF\u2010\u03b2) in human cancer","volume":"10","author":"Gold L.I.","year":"1999","journal-title":"Crit. Rev. Oncog."},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0844(1998120)16:4<227::AID-CBF787>3.0.CO;2-M"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1995.tb00919.x"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.240530404"},{"key":"e_1_2_7_37_2","first-page":"121","article-title":"The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes: transcriptional and posttranscriptional regulation, signal transduction, and cell\u2010type\u2010specific expression","volume":"151","author":"Vincenti M.","year":"2001","journal-title":"Methods Mol. Biol."}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2002.tb02774.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2002.tb02774.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T20:41:47Z","timestamp":1695674507000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2002.tb02774.x"}},"subtitle":["Potential Targets for Progestin\u2010Based Treatment of Endometriosis"],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["10.1111\/j.1749-6632.2002.tb02774.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2002.tb02774.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}